Clinical Trial Update: Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial assessing pharmacokinetics and safety of two dose regimens of lopinavir/ritonavir in HIV/TB co-infected patients on rifampicin-containing TB thera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Tuberculosis

Drugs mentioned

• Lopinavir/ritonavir (lopinavir/ritonavir)

Snippet

Sponsor: The HIV Netherlands Australia Thailand Research Collaboration | Conditions: HIV Infections, Tuberculosis | Phase 2 | Status: COMPLETED